Finance

Lists
HESTERBIO:NSE
Hester Biosciences Ltd
₹2,423.20
-2.20%
(-54.50) 1D
Aug 3, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for HESTERBIO...
Open
₹2,477.00
High
₹2,489.80
Low
₹2,420.00
Mkt. cap
20.61B
Avg. vol.
56.00K
Volume
6.34K
Dividend
0.45%
Quarterly dividend
₹2.75
Ex-dividend date
Jul 14, 2026
P/E ratio
15.27
52-wk high
₹2,683.60
52-wk low
₹1,239.30
EPS
₹158.68
Shares outstanding
8.51M
No. of employees
483
Open
₹2,477.00
High
₹2,489.80
Low
₹2,420.00
Mkt. cap
20.61B
Avg. vol.
56.00K
Volume
6.34K
Dividend
0.45%
Quarterly dividend
₹2.75
Ex-dividend date
Jul 14, 2026
P/E ratio
15.27
52-wk high
₹2,683.60
52-wk low
₹1,239.30
EPS
₹158.68
Shares outstanding
8.51M
No. of employees
483
News stories
From sources across the web
Profile
Hester Biosciences Limited is a publicly traded Indian animal and poultry vaccines manufacturing company, headquartered in Ahmedabad. Hester has plants situated in Gujarat and Nepal. Hester has a 30% share of the poultry vaccines market in India, making it the country's second largest poultry vaccine manufacturer. Hester is also the first commercial manufacturer of goat pox vaccine in India and manufactures PPR vaccines from both, Nigerian and Sungri strains. Wikipedia
About Hester Biosciences Ltd
CEO-
Employees483
Founded1983
Headquarters-
SectorBiotechnology
Websitehester.in
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
709.69M
774.15M
1.02B
788.87M
Cost of goods sold
193.19M
207.28M
251.52M
170.79M
Cost of revenue
193.19M
207.28M
251.52M
170.79M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
155.01M
155.18M
264.13M
148.84M
Operating expense
442.86M
433.25M
465.39M
444.32M
Total operating expenses
636.05M
640.53M
716.91M
615.11M
Operating income
73.64M
133.62M
299.41M
173.76M
Other non operating income
97.27M
6.69M
-133.21M
-
EBT including unusual items
170.36M
135.24M
250.89M
1.02B
EBT excluding unusual items
170.36M
135.24M
203.96M
163.33M
Income tax expense
27.05M
42.14M
85.42M
49.50M
Effective tax rate
15.88%
31.16%
34.05%
4.87%
Other operating expenses
244.31M
233.76M
58.89M
225.04M
Net income
144.49M
87.65M
159.83M
969.81M
Net profit margin
20.36%
11.32%
15.73%
122.94%
Earnings per share
-
-
-
-
Interest and investment income
-
-
15.79M
-
Interest expense
-22.07M
-18.22M
-15.77M
-30.80M
Net interest expenses
-22.07M
-18.22M
20.00K
-30.80M
Depreciation and amortization charges
43.54M
44.31M
59.14M
70.44M
EBITDA
116.32M
174.66M
330.34M
204.70M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps